Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory
Open Access
- 5 December 2023
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 95 (12) , e29273
Abstract
Detection of HIV drug resistance (HIVDR) is vital to successful anti‐retroviral therapy (ART). HIVDR testing to determine drug‐resistance mutations is routinely performed in Australia to guide ART choice in newly diagnosed people living with HIV or in cases of treatment failure. In 2022, our clinical microbiology laboratory sought to validate a next‐generation sequencing (NGS)‐based HIVDR assay to replace the previous Sanger‐sequencing (SS)‐based ViroSeq. NGS solutions for HIVDR offer higher throughput, lower costs and higher sensitivity for variant detection. We sought to validate the previously described low‐cost probe‐based NGS method (veSEQ‐HIV) for whole‐genome recovery and HIVDR‐testing in a diagnostic setting. veSEQ‐HIV displayed 100% and 98% accuracy in major and minor mutation detection, respectively, and 100% accuracy of subtyping (provided > 1000 mapped reads were obtained). Pairwise comparison exhibited low inter‐and intrarun variability across the whole‐genome (Jaccard index [J] = 0.993; J = 0.972) and the Pol gene (J = 0.999; J = 0.999), respectively. veSEQ‐HIV met all our pre‐set criteria based on WHO recommendations and successfully replaced ViroSeq in our laboratory. Scaling‐down veSEQ‐HIV to a limited batch size and sequencing on Illumina iSeq. 100, allowed easy implementation of the assay into the workflow of a small sequencing laboratory with minimal staff and equipment and the ability to meet clinically relevant test turn‐around times. As HIVDR‐testing moves from SS‐ to NGS‐based methods and new ART drugs come to market (particularly those with targets outside the Pol region), whole‐genome recovery using veSEQ‐HIV provides a robust, cost‐effective and “future‐proof” NGS method for HIVDR‐testing.Keywords
All Related Versions
This publication has 23 references indexed in Scilit:
- Deep sequencing for HIV-1 clinical managementVirus Research, 2017
- A national study of the molecular epidemiology of HIV-1 in Australia 2005–2012PLOS ONE, 2017
- Kraken: ultrafast metagenomic sequence classification using exact alignmentsGenome Biology, 2014
- Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment OutcomesThe Journal of Infectious Diseases, 2009
- Minority Quasispecies of Drug‐Resistant HIV‐1 That Lead to Early Therapy Failure in Treatment‐Naive and ‐Adherent PatientsClinical Infectious Diseases, 2009
- HIV diagnoses in Australia: diverging epidemics within a low‐prevalence countryMedical Journal of Australia, 2007
- Rationale and Uses of a Public HIV Drug‐Resistance DatabaseThe Journal of Infectious Diseases, 2006
- Web Resources for HIV Type 1 Genotypic-Resistance Test InterpretationClinical Infectious Diseases, 2006
- Multiple sequence alignment with the Clustal series of programsNucleic Acids Research, 2003
- Human immunodeficiency virus reverse transcriptase and protease sequence databaseNucleic Acids Research, 2003